ATC Group: J07AG Haemophilus influenzae B vaccines

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07AG in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07A Bacterial vaccines
4 J07AG Haemophilus influenzae B vaccines

Group J07AG contents

Code Title
J07AG01 Haemophilus influenzae B, purified antigen conjugated
J07AG51 Haemophilus influenzae B, combinations with toxoids
J07AG52 Haemophilus influenzae B, combinations with pertussis and toxoids
J07AG53 Haemophilus influenzae B, combinations with meningococcus C, conjugated
J07AG54

Active ingredients in J07AG

Active Ingredient Description
Haemophilus influenzae B

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

Haemophilus influenzae B, combinations with toxoids